Expression of concern
The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer
Paper Information
Record ID:
31311
Author(s):
Journal:
Publication Date:
March 21, 2006
Retraction Date:
August 02, 2021
(4.3 years years ago)
Subjects:
Broad Categories:
Biology
Biology
Institutions:
- Department of Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
- Department of Biostatistics and Applied Mathematics, University of Texas M.D. Anderson Cancer Center, Houston, Texas
- Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
- Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, Iowa
Country:
🇺🇸 United StatesArticle Type:
Publisher:
American Association for Cancer Research
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reason:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1158/1078-0432.CCR-21-2121Citations (171)
171
Total Citations16
Post-Retraction(9.4%)
153
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
4
Within 1 year
5
After 2+ years
1416
Days since retraction (latest)
Changes in the expression of MMP2, MMP9, and ColIV in stromal cells in oral squamous tongue cell carcinoma: relationships and prognostic implications
Haixia Fan, Haixia Li, Dong Chen et al. (5 authors)
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Oct 2012
83 citations
83 citations
3199 days before retraction
Matrix Metalloproteinases and Cancer
Müfide Öncel
European Journal of Basic Medical Sciences
Open Access
Published: Sep 2012
9 citations
9 citations
3257 days before retraction
Paper citing The Clinical Relevance of Stromal Matrix Metallopr...
Unknown Authors
Unknown Journal
Published: Aug 2012
3288 days before retraction
Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion
Xiaoxia Hu, Danrong Li, Wei Zhang et al. (6 authors)
Archives of Gynecology and Obstetrics
Published: Jul 2012
119 citations
119 citations
3295 days before retraction
Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer
Erienne M.V. de Cuba, R. Kwakman, Marjolein van Egmond et al. (7 authors)
Virchows Archiv
Published: Jul 2012
61 citations
61 citations
3297 days before retraction
Clinical Relevance of MMP and TIMP Measurements in Cancer Tissue
Omer Bashir, Jian Cao, Stanley Zucker
Unknown Journal
Published: Jun 2012
1 citation
1 citation
3344 days before retraction
Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis
Ksenya Shchors, Hiroaki Nozawa, Jian Xu et al. (7 authors)
Oncogene
Open Access
Published: Mar 2012
53 citations
53 citations
3437 days before retraction
Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo
Fengjun Guo, Jingyan Tian, Manhua Cui et al. (5 authors)
Molecular Medicine Reports
Open Access
Published: Mar 2012
16 citations
16 citations
3438 days before retraction
Psychoneuroimmunologie und Krebs
Jochen Hefner, Herbert Csef
best practice onkologie
Published: Feb 2012
3470 days before retraction
Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
Balázs Győrffy, András Lánczky, Zoltán Szállási
Endocrine Related Cancer
Published: Jan 2012
926 citations
926 citations
3477 days before retraction
Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion
Xiaoxia HuDanrong, Liwei Zhang, Jie ZhouBujian et al. (4 authors)
Unknown Journal
Published: Jan 2012
3501 days before retraction
Implications of Microvesicle and Cell Surface Protein Shedding for Biomarker Studies, Cancerogenesis, and Therapeutic Target Discovery in Ovarian Cancer
Katarina Černe, Borut Kobal
Deleted Journal
Published: Jan 2012
2 citations
2 citations
3501 days before retraction
AUTHOR COPY ONLY Implementing an online tool for genome- wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
Balazs Gyo, Zoltán Szállási
Unknown Journal
Published: Jan 2012
3501 days before retraction
IMPLEMENTING AN ONLINE TOOL FOR GENOME-WIDE VALIDATION OF 1 SURVIVAL-ASSOCIATED BIOMARKERS IN OVARIAN-CANCER USING 2
Balázs Gyirffy, András Lánczky, Zoltán Szállási et al. (4 authors)
Unknown Journal
Published: Jan 2012
3501 days before retraction
Epithelial ovarian cancer: A feasible plan for adjunctive treatment using simultaneous acyclovir, ambrisentan, captopril, disulfiram, fluvoxamine-augmented ramelteon, icatibant, imiquimod peritoneal lavage, and plerixafor
Richard E. Kast
journal of cancer therapeutics and research
Open Access
Published: Jan 2012
4 citations
4 citations
3501 days before retraction
Expression of MMP-2, −7, −9, MT1-MMP and TIMP-1 and −2 has no prognostic relevance in patients with advanced epithelial ovarian cancer
J.-L. Brun, A. Cortez, Bénédicte Lesieur et al. (6 authors)
Oncology Reports
Open Access
Published: Dec 2011
45 citations
45 citations
3511 days before retraction
Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules
Monther Al‐Alwan, Safiah Olabi, Hazem Ghebeh et al. (8 authors)
PLoS ONE
Open Access
Published: Nov 2011
89 citations
89 citations
3559 days before retraction
Peptides in cancer nanomedicine: Drug carriers, targeting ligands and protease substrates
Xiaoxiang Zhang, Henry S. Eden, Xiaohong Chen
Journal of Controlled Release
Open Access
Published: Oct 2011
233 citations
233 citations
3566 days before retraction
Prognostic biomarkers in ovarian cancer
Jie Huang, Wei Hu, Anil K. Sood
Cancer Biomarkers
Open Access
Published: Oct 2011
41 citations
41 citations
3580 days before retraction
Conditionally Replicating Adenovirus Expressing TIMP2 Increases Survival in a Mouse Model of Disseminated Ovarian Cancer
Sherry W. Yang, Diptiman Chanda, James J. Cody et al. (8 authors)
PLoS ONE
Open Access
Published: Oct 2011
11 citations
11 citations
3582 days before retraction
Intraoperative Imaging in Ovarian Cancer: Fact or Fiction?
Lucia M.A. Crane, Marleen van Oosten, Rick G. Pleijhuis et al. (8 authors)
Molecular Imaging
Open Access
Published: Jul 2011
21 citations
21 citations
3685 days before retraction
Characterization and Targeting of the Aldehyde Dehydrogenase Subpopulation in Ovarian Cancer
Jr Landen, N. Charles
Unknown Journal
Published: Jul 2011
3685 days before retraction
Psychoneuroimmunologie und Krebs
Jochen Hefner, Herbert Csef
Der Onkologe
Published: Jun 2011
3 citations
3 citations
3706 days before retraction
Etude de deux chimiokines CXCL12/SDF-1 et fractalkine (FKN)/CX3CL1 dans le cancer épithélial des ovaires
Salam Nasreddine
Unknown Journal
Published: Jun 2011
3710 days before retraction
Ovarian cancer cells with different drugresistant abilities: a comparison of migration and invasion capability
Dan Wang, Chao Chen, Hui Ning
Academic Journal of Second Military Medical University
Published: May 2011
3717 days before retraction
Molecular Targeted Therapy in Ovarian Cancer
Roshni Kalachand, Bryan T. Hennessy, Maurie Markman
Drugs
Published: May 2011
19 citations
19 citations
3746 days before retraction
Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer
William M. Merritt, Aparna A. Kamat, Jee Young Hwang et al. (19 authors)
Cancer Biology & Therapy
Open Access
Published: Dec 2010
62 citations
62 citations
3883 days before retraction
Expression pattern of matrix metalloproteinases in human gynecological cancer cell lines
Andrea Schröpfer, Ulrike Kämmerer, Michaela Kapp et al. (6 authors)
BMC Cancer
Open Access
Published: Oct 2010
69 citations
69 citations
3946 days before retraction
Matrix Metalloproteinases 2, 7, and 9 and Tissue Inhibitor of Metalloproteinases-1 in Tumors and Serum of Patients with Ovarian Neoplasms
Е. С. Герштейн, Н. В. Левкина, M. A. Digayeva et al. (6 authors)
Bulletin of Experimental Biology and Medicine
Published: Sep 2010
21 citations
21 citations
3961 days before retraction
Epithelial ovarian cancer: Focus on targeted therapy
Kyriaki Pliarchopoulou, Dimitrios Pectasides
Critical Reviews in Oncology/Hematology
Published: Aug 2010
35 citations
35 citations
4017 days before retraction
Inflammatory processes and depressive-like behavior in a syngeneic model of ovarian cancer
Donald M. Lamkin
Unknown Journal
Published: Jul 2010
1 citation
1 citation
4050 days before retraction
Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours
Mei Lin Tan, Peter Choong, Crispin R. Dass
Cancer Cell International
Open Access
Published: Mar 2010
27 citations
27 citations
4149 days before retraction
Effect of TIMP-1 and MMP in Pterygium Invasion
Yi-Yu Tsai, Chun-Chi Chiang, Kun-Tu Yeh et al. (5 authors)
Investigative Ophthalmology & Visual Science
Published: Mar 2010
73 citations
73 citations
4154 days before retraction
Effects of Oral Contraceptives or a Gonadotropin-Releasing Hormone Agonist on Ovarian Carcinogenesis in Genetically Engineered Mice
Iris L. Romero, Ilyssa O. Gordon, Sujatha Jagadeeswaran et al. (10 authors)
Obstetrical & Gynecological Survey
Published: Dec 2009
10 citations
10 citations
4232 days before retraction
Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer
Samir F. Zohny, Salah T. Fayed
Medical Oncology
Published: Nov 2009
52 citations
52 citations
4270 days before retraction
Matrix Metalloproteinases As Novel Biomarker s and Potential Therapeutic Targets in Human Cancer
Roopali Roy, Jiang Yang, Marsha A. Moses
Journal of Clinical Oncology
Open Access
Published: Sep 2009
824 citations
824 citations
4345 days before retraction
Effects of Oral Contraceptives or a Gonadotropin-Releasing Hormone Agonist on Ovarian Carcinogenesis in Genetically Engineered Mice
Iris L. Romero, Ilyssa O. Gordon, Sujatha Jagadeeswaran et al. (10 authors)
Cancer Prevention Research
Open Access
Published: Sep 2009
16 citations
16 citations
4353 days before retraction
The Use of Predictive or Prognostic Genetic Biomarkers in Endometrial and Other Hormone-Related Cancers: Justification for Extensive Candidate Gene Single Nucleotide Polymorphism Studies of the Matrix Metalloproteinase Family and their Inhibitors
Tracy A. O’Mara, Judith A. Clements, Amanda B. Spurdle
Cancer Epidemiology Biomarkers & Prevention
Open Access
Published: Sep 2009
19 citations
19 citations
4353 days before retraction
Assessment of preoperative serum prolidase activity in epithelial ovarian cancer
Hakan Camuzcuoğlu, Dağıstan Tolga Ariöz, Harun Toy et al. (6 authors)
European Journal of Obstetrics & Gynecology and Reproductive Biology
Published: Aug 2009
36 citations
36 citations
4365 days before retraction
Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity
Chun‐Houh Chen, Chih‐Yen Chien, C‐C Huang et al. (10 authors)
Oncogene
Published: Jun 2009
83 citations
83 citations
4431 days before retraction
Epidermal Growth Factor Receptor–Mediated Membrane Type 1 Matrix Metalloproteinase Endocytosis Regulates the Transition between Invasive versus Expansive Growth of Ovarian Carcinoma Cells in Three-Dimensional Collagen
Natalie M. Moss, Yueying Liu, Jeff Johnson et al. (8 authors)
Molecular Cancer Research
Open Access
Published: Jun 2009
33 citations
33 citations
4436 days before retraction
Retraction Notice: An Outlook on Ovarian Cancer and Borderline Ovarian Tumors: Focus on Genomic and Proteomic Findings
Andrea Tinelli, Daniele Vergara, Roberta Martignago et al. (6 authors)
Current Genomics
Open Access
Published: Jun 2009
18 citations
18 citations
4445 days before retraction
Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients
Li Wang, Michele C. Madigan, Hongmin Chen et al. (8 authors)
Gynecologic Oncology
Published: May 2009
47 citations
47 citations
4459 days before retraction
EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer
Aparna A. Kamat, Donna Coffey, William M. Merritt et al. (10 authors)
Cancer
Open Access
Published: Apr 2009
66 citations
66 citations
4480 days before retraction
EGF-Receptor Regulation of Matrix Metalloproteinases in Epithelial Ovarian Carcinoma
Laurie G. Hudson, Natalie M. Moss, M. Sharon Stack
Future Oncology
Open Access
Published: Apr 2009
36 citations
36 citations
4490 days before retraction
Cancer Modeling: How Far Can We Go?
Kenneth G. Mantón, Igor Akushevich, Julia Kravchenko
Statistics in the health sciences
Published: Jan 2009
4596 days before retraction
Biobehavioral Influences on Matrix Metalloproteinase Expression in Ovarian Carcinoma
Susan K. Lutgendorf, Donald M. Lamkin, Nicholas B. Jennings et al. (11 authors)
Clinical Cancer Research
Open Access
Published: Nov 2008
154 citations
154 citations
4657 days before retraction
Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: High level expression in clear cell carcinoma
Brian P. Adley, Kara J. Gleason, Ximing J. Yang et al. (4 authors)
Gynecologic Oncology
Open Access
Published: Oct 2008
45 citations
45 citations
4658 days before retraction
Diagnostic and prognostic role of matrix metalloproteases in cancer
Pia Vihinen, Risto Ala‐aho, Veli‐Matti Kähäri
Expert Opinion on Medical Diagnostics
Published: Sep 2008
3 citations
3 citations
4718 days before retraction
Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer
Angiolo Gadducci, Stefania Cosio, Roberta Tana et al. (4 authors)
Critical Reviews in Oncology/Hematology
Published: Jul 2008
82 citations
82 citations
4779 days before retraction
Quick Stats
Total Citations:
171
Years Since Retraction:
4.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025